PMN SCHEDULE 13G/A: SEC filing
Great Point Partners LLC
Filed with the SEC on · accession 0001172661-26-005410
PMN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. A report the company filed with the SEC (the US market regulator).
Summary of the filing
Great Point Partners LLC filed an amended Schedule 13G reporting beneficial ownership of 650,731 common shares (6.77%) of ProMIS Neurosciences, including shares underlying warrants, as a passive investor.
Key details
✦ Ask GOAX AI about this filing — what it means for PMN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for PMN?
Click hereFrequently asked questions
What did PMN file with the SEC on Nov 16, 2026?
PMN filed a SCHEDULE 13G/A (SEC filing). Great Point Partners LLC filed an amended Schedule 13G reporting beneficial ownership of 650,731 common shares (6.77%) of ProMIS Neurosciences, including shares underlying warrants, as a passive investor.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
Other PMN SEC filings
- 8-K · SEC filingNov 12, 2026
- SCHEDULE 13G · SEC filingNov 12, 2026
- 8-K · SEC filingNov 12, 2026
- 10-Q · SEC filingNov 12, 2026
- SCHEDULE 13G/A · SEC filingAug 14, 2026
- 10-Q · SEC filingAug 13, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- SCHEDULE 13G/A · SEC filingAug 13, 2026
- 8-K · SEC filingAug 13, 2026
- 8-K · Fda approvalJul 28, 2026
Get alerts when PMN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days